Australia delivers for ISCT 2019
One of the world’s largest scientific conferences in cell, gene and regenerative medicine made its way to Melbourne for the International Society for Cell and Gene Therapy (ISCT) 2019 Annual Scientific Meeting.
Global leader ISCT (International Society for Cell & Gene Therapy) is a growing organisation of clinicians, regulators, researchers, technologists and industry partners working to translate cell and gene therapies into safe and effective therapies to improve patients’ lives worldwide.
More than 1,500 cell therapy experts across five geographic regions and representatives from over 40 countries attended ISCT 2019 from 29 May-1 June to exchange knowledge and share best practice in an exciting and emerging field with enormous potential to revolutionise the treatment of disease. Melbourne was the chosen platform for the discussion of new research results, future developments and ground-breaking applications.
“It’s no coincidence that one of the most influential cell and gene therapy conferences is being held in one of the world’s most productive areas for cell and gene therapy research and innovation,” says John Rasko, ISCT President, Head of the Gene and Stem Cell Therapy Program at the University of Sydney, Australia. “The support of the MCB and the Victorian government has been absolutely incredible. We’ve had increased visibility, increased attendance and a greater level of excitement than we’ve ever experienced before.”
The unbeatable combination of Victoria’s knowledge base, Melbourne stakeholders’ collaborative approach and the city’s successful track record in hosting large prestigious events was key to the successful bid for Australia.
Julia Swanson, acting Chief Executive Officer, Melbourne Convention Bureau, says: “Melbourne has a proven track record in hosting important medical and scientific meetings. Unique to our bid process is the collaboration and unified approach between the Bureau, government, associations and industry partners.”
ISCT 2019 was a critical moment highlighting the promising therapeutic potential of cell and gene therapies, bringing together key players in the development and now delivery of Kymriah® CAR-T therapy to patients for the first time. Therapeutic Innovation Australia (TIA) announced $8.8 million investment in cell and gene therapy facilities in Australia over the next four years.
- Melbourne won the bid thanks to the successful collaboration and partnership of the Melbourne Convention Bureau (MCB), the Victorian government, The City of Melbourne, industry partners, local sponsors and the local health and medical community. The unity of all stakeholders showed Melbourne’s winning approach to business
- Victoria’s vibrant cellular community, with local cell and gene therapy and regenerative medicine professionals making substantial contributions to the field in basic and applied research, was vital in attracting the event
- Melbourne’s reputation for delivering a customised event and providing numerous experiences for delegates to enjoy both pre and post in the city and the wider regions proved a winning draw.
Event at a glance
ISCT 2019 Annual Scientific Meeting (International Society of Cellular Therapy)
Venue: Melbourne Convention and Exhibition Centre (MCEC), 29 May – 1 June 2019
Attendance: 1,100 + delegates from over 40 countries
Room nights: 3,294
400+ Partnering Meetings
10+ Networking Events
Economic impact: + $7.1 million
To discover why there’s nothing like Australia for business events contact Kelly Maynard email@example.com
Published Date: 02/09/2019